Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Mutation analysis and copy number alterations of KIF23 in non-small-cell lung cancer exhibiting KIF23 over-expression
Umeå University, Faculty of Medicine, Department of Medical Biosciences, Medical and Clinical Genetics.
Show others and affiliations
2017 (English)In: OncoTargets and Therapy, ISSN 1178-6930, Vol. 10, 4969-4979 p.Article in journal (Refereed) Published
Abstract [en]

KIF23 was recently suggested to be a potential molecular target for the treatment of lung cancer. This proposal is based on elevated expression of KIF23 in several tumors affecting breast, lung, brain, and liver, and also on the presence of KIF23 mutations in melanoma and colorectal cancer. Recently, we identified a mutation in the KIF23 gene causing a rare hereditary form of dyserythropoietic anemia (CDA III) with predisposition to blood cancer. We suggested that KIF23 overexpression in tumors might be due to the presence of activating somatic mutations, and therefore, mutation screening of the KIF23 in 15 non-small-cell lung cancer (NSCLC) cases with elevated expression level of KIF23 was undertaken. Eight sequence variants were found in all samples. Furthermore, one variant was present in two cases, and one variant was case specific. Nine variants were previously reported while one variant lacks frequency information. Nine of ten cases available for single nucleotide polymorphism-array analysis demonstrated aberrant karyotypes with additional copy of entire chromosome 15. Thus, no activating somatic mutations in coding regions of the KIF23 were found. Furthermore, no mutations were detected in cell cycle genes homology region in KIF23 promoter responsible for p53-dependent repression of KIF23 expression. We showed that the elevated level of KIF23 could be due to additional copy of chromosome 15 demonstrated in 90% of NSCLC cases analyzed in this study. Considering the crucial role of KIF23 in the final step of mitosis, the gene is a potential molecular marker, and for better understanding of its role in cancer development, more tumors should be analyzed.

Place, publisher, year, edition, pages
DOVE MEDICAL PRESS LTD , 2017. Vol. 10, 4969-4979 p.
Keyword [en]
KIF23, overexpression, mutation, copy number alteration, CNA, lung cancer
National Category
Medical Genetics
Identifiers
URN: urn:nbn:se:umu:diva-141225DOI: 10.2147/OTT.S138420ISI: 000412742500004OAI: oai:DiVA.org:umu-141225DiVA: diva2:1154885
Available from: 2017-11-06 Created: 2017-11-06 Last updated: 2017-11-06Bibliographically approved

Open Access in DiVA

fulltext(9629 kB)2 downloads
File information
File name FULLTEXT02.pdfFile size 9629 kBChecksum SHA-512
fb8af390004035f3c52156af0d5da3a106dd26122b6acdc1b3b9f8a75c15d265e647c83abed5dc994fb92a9bb54bb1e3d5e64cdf0f2629327f525f3480dc81f4
Type fulltextMimetype application/pdf

Other links

Publisher's full text

Search in DiVA

By author/editor
Vikberg, Ann-LouiseGolovleva, Irina
By organisation
Medical and Clinical Genetics
In the same journal
OncoTargets and Therapy
Medical Genetics

Search outside of DiVA

GoogleGoogle Scholar
Total: 2 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 71 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf